ArticleChemical science2026
Glycopolymer-based nanofibers with tunable polyelectrolyte content for modulating cellular interactions and drug delivery.
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polymer-based nanoparticles are emerging as a promising class of nanomedicines, yet are typically limited to spherical morphologies with limited control over particle size. As nanoparticle morphology, size, dispersity and surface chemistry dictate their biological performance, developing nanoparticles with precise control over these parameters is essential for the design of next-generation nanomedicines. Here, we report one-dimensional triblock nanofibers with a dual-functional corona, that combine the minimal cytotoxicity of a polyfructose glycopolymer and the improved cellular interaction of polyamine polyelectrolytes. Living crystallization-driven self-assembly enables precise length and dispersity control of poly(fluorene trimethylene carbonate)-
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.